Bifogade filer
Kurs
+2,63%
Likviditet
1,69 MDKK
Kalender
Est. tid* | ||
2026-02-03 | 08:00 | Bokslutskommuniké 2025 |
2025-10-21 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-07-22 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-04-29 | - | Kvartalsrapport 2025-Q1 |
2025-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
2025-03-12 | - | Årsstämma |
2025-02-05 | - | Bokslutskommuniké 2024 |
2024-10-22 | - | Kvartalsrapport 2024-Q3 |
2024-07-23 | - | Kvartalsrapport 2024-Q2 |
2024-04-23 | - | Kvartalsrapport 2024-Q1 |
2024-03-13 | - | Årsstämma |
2024-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
2024-03-12 | - | Årsstämma |
2024-01-30 | - | Bokslutskommuniké 2023 |
2023-10-24 | - | Kvartalsrapport 2023-Q3 |
2023-07-25 | - | Kvartalsrapport 2023-Q2 |
2023-04-25 | - | Kvartalsrapport 2023-Q1 |
2023-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
2023-03-10 | - | Årsstämma |
2023-01-31 | - | Bokslutskommuniké 2022 |
2022-10-25 | - | Kvartalsrapport 2022-Q3 |
2022-07-21 | - | Kvartalsrapport 2022-Q2 |
2022-04-26 | - | Kvartalsrapport 2022-Q1 |
2022-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
2022-03-08 | - | Årsstämma |
2022-02-01 | - | Bokslutskommuniké 2021 |
2021-10-26 | - | Kvartalsrapport 2021-Q3 |
2021-07-22 | - | Kvartalsrapport 2021-Q2 |
2021-04-27 | - | Kvartalsrapport 2021-Q1 |
2021-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
2021-03-08 | - | Årsstämma |
2021-02-02 | - | Bokslutskommuniké 2020 |
2020-10-27 | - | Kvartalsrapport 2020-Q3 |
2020-07-23 | - | Kvartalsrapport 2020-Q2 |
2020-04-30 | - | Kvartalsrapport 2020-Q1 |
2020-03-13 | - | X-dag ordinarie utdelning EMBLA 0.15 DKK |
2020-03-12 | - | Årsstämma |
2020-02-04 | - | Bokslutskommuniké 2019 |
2019-10-22 | - | Kvartalsrapport 2019-Q3 |
2019-07-25 | - | Kvartalsrapport 2019-Q2 |
2019-04-30 | - | Kvartalsrapport 2019-Q1 |
2019-03-08 | - | X-dag ordinarie utdelning EMBLA 0.14 DKK |
2019-03-07 | - | Årsstämma |
2019-02-05 | - | Bokslutskommuniké 2018 |
2018-10-24 | - | Kvartalsrapport 2018-Q3 |
2018-07-25 | - | Kvartalsrapport 2018-Q2 |
2018-04-25 | - | Kvartalsrapport 2018-Q1 |
2018-03-09 | - | X-dag ordinarie utdelning EMBLA 0.13 DKK |
2018-03-08 | - | Årsstämma |
2018-02-05 | - | Bokslutskommuniké 2017 |
2017-10-24 | - | Kvartalsrapport 2017-Q3 |
2017-07-25 | - | Kvartalsrapport 2017-Q2 |
2017-04-27 | - | Kvartalsrapport 2017-Q1 |
2017-03-10 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
2016-03-11 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
2016-03-10 | - | Årsstämma |
2016-02-02 | - | Bokslutskommuniké 2015 |
2015-10-22 | - | Kvartalsrapport 2015-Q3 |
2015-07-23 | - | Kvartalsrapport 2015-Q2 |
2015-04-29 | - | Kvartalsrapport 2015-Q1 |
2015-03-12 | - | Årsstämma |
2015-02-05 | - | Bokslutskommuniké 2014 |
2014-10-24 | - | Analytiker möte 2014 |
2014-10-23 | - | Kvartalsrapport 2014-Q3 |
2014-07-25 | - | Analytiker möte 2014 |
2014-07-24 | - | Kvartalsrapport 2014-Q2 |
2014-04-30 | - | Analytiker möte 2014 |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-03-14 | - | Årsstämma |
2014-02-05 | - | Bokslutskommuniké 2013 |
2013-10-24 | - | Analytiker möte 2013 |
2013-10-23 | - | Kvartalsrapport 2013-Q3 |
2013-07-24 | - | Kvartalsrapport 2013-Q2 |
2013-04-24 | - | Kvartalsrapport 2013-Q1 |
2013-03-15 | - | Årsstämma |
2013-02-06 | - | Bokslutskommuniké 2012 |
2012-11-28 | - | Kapitalmarknadsdag 2012 |
2012-11-27 | - | Kapitalmarknadsdag 2012 |
2012-10-24 | - | Analytiker möte 2012 |
2012-10-23 | - | Kvartalsrapport 2012-Q3 |
2012-07-25 | - | Kvartalsrapport 2012-Q2 |
2012-04-24 | - | Kvartalsrapport 2012-Q1 |
2012-03-16 | - | Årsstämma |
2012-02-08 | - | Bokslutskommuniké 2011 |
2011-10-27 | - | Kvartalsrapport 2011-Q3 |
2011-07-28 | - | Kvartalsrapport 2011-Q2 |
2011-03-04 | - | Årsstämma |
Beskrivning
Land | Island |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Medicinteknik |
Announcement no. 25/2022
20 April 2022
New R&D Leadership
Dr. Kristleifur Kristjánsson, Executive Vice President of Research and Development, has decided to retire from 1 July 2022 after a decade with Össur. Hildur Einarsdóttir has been appointed Executive Vice President of Research and Development and will become a member of the Össur Executive Committee. Mrs. Einarsdóttir has been with Össur in various roles since 2009. She is an Electrical Engineer from the University of Iceland and holds a Master's degree in Biomedical Engineering with focus on Computational Neuroscience from Imperial College London.
"Hildur Einarsdóttir has been a valuable leader within Össur R&D and Global Marketing during her 13 years with the Company. She has a proven track record of strategy execution and leading global teams. Her industry knowledge and passion for innovation will further advance Össur's technological leadership and we look forward to having her join our Executive Committee. On behalf of everyone at Össur, we thank Kristleifur Kristjánsson for his valuable contribution to our Company over the years and wish him all the best in his retirement", said Sveinn Sölvason, Össur President and CEO.
Further information
Edda Lára Lúðvígsdóttir, Investor Relations Director, eludvigsdottir@ossur.com,+354 844 4759
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors
About Össur
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized "Technology Pioneer" with a rich 50-year history, Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women's Empowerment Principles, contributes to the UN Sustainable Development Goals and became Carbon Neutral in 2021. Össur operates globally and employs around 4,000 employees. www.ossur.com